Kolexia
Perret Bertrand
Biologie médicale
Hôpital Purpan
Toulouse, France
60 Activités
1 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie coronarienne Maladie des artères coronaires Athérosclérose Cardiopathies Hypertension artérielle Dyslipidémies Pré-éclampsie Artériopathies carotidiennes Insulinorésistance

Industries

MSD
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Associations between physical activity levels and ATPase inhibitory factor 1 concentrations in older adults.
Journal of sport and health science   23 septembre 2023
Plasma Level of ATPase Inhibitory Factor 1 (IF1) and intrinsic capacity in community-dwelling older adults: Prospective data from the MAPT Study.
The journals of gerontology. Series A, Biological sciences and medical sciences   06 juin 2023
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study.
Diabetes & metabolism   26 septembre 2022
Bertrand Perret, le coach qui a relancé Caro Garcia vers les sommets
20 Minutes   08 septembre 2022
L'Alsacien Bertrand Perret, le coach bourlingueur de Caroline Garcia ...
L'Alsace   08 septembre 2022
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk.
Current opinion in lipidology   06 avril 2022
The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
Antioxidants & redox signaling   04 janvier 2022
Le corps gros # métamorphoses
Youtube @ Ramsay Santé   01 mars 2021
Prediction of coronary heart disease incidence in a general male population by circulating non-coding small RNA sRNY1-5p in a nested case-control study.
Scientific reports   19 janvier 2021
Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk.
Vascular pharmacology   25 septembre 2020